𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The potential and limits for clinical trials for early Alzheimer’s disease and some recommendations

✍ Scribed by L. S. Schneider

Publisher
Springer
Year
2010
Tongue
English
Weight
70 KB
Volume
14
Category
Article
ISSN
1279-7707

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The ADAS-cog and clinically meaningful c
The ADAS-cog and clinically meaningful change in the VISTA clinical trial of galantamine for Alzheimer's disease
✍ Kenneth Rockwood; Sherri Fay; Mary Gorman 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 184 KB 👁 2 views

## Abstract ## Background A minimum 4‐point change at 6 months on the Alzheimer's disease assessment scale‐cognitive subscale (ADAS‐cog) is deemed clinically important, but this cut‐point has been little studied in relation to clinical meaningfulness. In an investigator‐initiated, clinical trial o